Advertisement
Screener

PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) Auditor

PROTHENA CORPORATION PUBLIC LIMITED COMPANY Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-27: Fiscal year end 2025-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location San Francisco, CA.
  • 2025-02-27: Fiscal year end 2024-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location San Francisco, CA.
  • 2024-02-22: Fiscal year end 2023-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location San Francisco, CA.
  • 2023-02-28: Fiscal year end 2022-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location San Francisco, CA.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-272025-12-31KPMG LLP185San Francisco, CAYes
2025-02-272024-12-31KPMG LLP185San Francisco, CAYes
2024-02-222023-12-31KPMG LLP185San Francisco, CAYes
2023-02-282022-12-31KPMG LLP185San Francisco, CAYes
2022-02-252021-12-31KPMG LLP185San Francisco, CAYes
2021-02-262020-12-31KPMG LLPSan Francisco, CaliforniaNo
2020-03-032019-12-31KPMG LLPSan Francisco, California
2019-03-152018-12-31KPMG LLPSan Francisco, California
2018-02-262017-12-31KPMG LLPSan Francisco, California
2017-02-272016-12-31KPMG LLPSan Francisco, California
2016-02-252015-12-31KPMG LLPSan Francisco, California
2015-03-132014-12-31KPMG LLPSan Francisco, California
2014-03-072013-12-31KPMG LLPSan Francisco, California
2013-03-292012-12-31KPMG LLPSan Francisco, California

Similar stocks

Stock NameCountryMarket CapPE Ratio
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10